Skip to main content
Log in

Sacubitril/valsartan cost effective for HF in Italy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. New York Heart Association

Reference

  • D'Angiolella LS, et al. Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context. European Journal of Heart Failure : 28 Aug 2017. Available from: URL: http://doi.org/10.1002/ejhf.919

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sacubitril/valsartan cost effective for HF in Italy. PharmacoEcon Outcomes News 786, 32 (2017). https://doi.org/10.1007/s40274-017-4322-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4322-z

Navigation